Evaluation of neoadjuvant weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer

被引：1
|
作者：
Nagayama, A. [1 ]
Matsui, A. [1 ]
Tachibana, A. [2 ]
Suzuki, N. [3 ]
Hirata, M. [4 ]
Oishi, Y. [5 ]
Hamaguchi, Y. [6 ]
Murata, Y. [7 ]
Okamoto, Y. [8 ]
机构：
[1] Natl Hosp Org, Tokyo Med Ctr, Surg, Tokyo, Japan
[2] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Breast Surg, Tokyo, Japan
[3] Omori Red Cross Hosp, Breast Surg, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Breast Surg, Tokyo, Japan
[5] Nissan Tamagawa Hosp, Breast Surg, Tokyo, Japan
[6] Futakotamagawa Breast Clin, Breast Surg, Tokyo, Japan
[7] Natl Hosp Org, Tokyo Med Ctr, Pathol, Tokyo, Japan
[8] Toho Univ, Breast Surg, Med Ctr, Ohashi Hosp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw365.75
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
296P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Albumin-bound paclitaxel: In metastatic breast cancer
    Robinson D.M.
    Keating G.M.
    Drugs, 2006, 66 (7) : 941 - 948
  • [32] Randomized phase II trial of nanoparticle albumin-bound paclitaxel in three dosing schedules with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (MBC)
    Conlin, A. K.
    Hudis, C. A.
    Bach, A.
    Moynahan, M.
    Lake, D.
    Forero-Torres, A.
    Wright, G.
    Hackney, M.
    Clawson, A.
    Seidman, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
    Ota, Daisuke
    Akatsuka, Sotaro
    Nishi, Tsunehiro
    Kato, Takao
    Takeuchi, Masashi
    Tsuji, Munechika
    Fukuuchi, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (12) : 6903 - 6907
  • [34] Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer A retrospective observational study
    Oi, Hajime
    Matsuda, Toshiaki
    Kimura, Tomoki
    Morise, Masahiro
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Kataoka, Kensuke
    Kondoh, Yasuhiro
    MEDICINE, 2022, 101 (06) : E28863
  • [35] A phase 2 study of de-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low risk pure HER2 breast cancer
    Tanaka, Satoru
    Morishima, Hirotaka
    Oda, Naofumi
    Matsunami, Nobuki
    Takashima, Tsutomu
    Noda, Satoru
    Kashiwagi, Shinichiro
    Tauchi, Yukie
    Asano, Yuka
    Kimura, Kosei
    Fujioka, Hiruya
    Terasawa, Risa
    Kawaguchi, Kanako
    Ikari, Ayana
    Morimoto, Takashi
    Michishita, Shintaro
    Kobayashi, Toshihiro
    Sakane, Junna
    Nitta, Toshikatsu
    Sato, Nayuko
    Hokimoto, Norihiro
    Nishida, Yukihiro
    Iwamoto, Mitsuhiko
    CANCER RESEARCH, 2020, 80 (04)
  • [36] Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia
    Lohmann, A. E.
    Speers, C. H.
    Chia, S. K.
    CURRENT ONCOLOGY, 2013, 20 (02) : 97 - 103
  • [37] Nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy in patients receiving neoadjuvant or adjuvant chemotherapy for breast cancer
    Yoshidome, Katsuhide
    Morimoto, Takashi
    Matsunami, Nobuki
    Tsunashima, Ryo
    Tsukamoto, Fumine
    Ryo, Toshio
    Nishida, Yukihiro
    Shimo, Toshiro
    Anno, Kana
    Shimada, Mayumi
    Udo, Midori
    Kagawa, Masakazu
    Morishima, Hirotaka
    Oda, Naofumi
    CANCER RESEARCH, 2018, 78 (04)
  • [38] Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.
    Khasraw, Mustafa
    Mukaro, Violet Rudo
    West, Linda
    White, Karen
    Rippy, Elisabeth
    Brandt, Conrad
    Tobler, Robert
    Murphy, Caitlin Clare
    Collins, Ian M.
    Baron-Hay, Sally E.
    Ashley, David M.
    Patil, Sujata
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Albumin-bound paclitaxel (Abraxane) for advanced breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1208): : 39 - 40
  • [40] A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer
    Hirano, A.
    Hattori, A.
    Kamimura, M.
    Ogura, K.
    Kim, N.
    Setoguchi, Y.
    Okubo, F.
    Inoue, H.
    Jibiki, N.
    Miyamoto, R.
    Kinoshita, J.
    Kimura, K.
    Fujibayashi, M.
    Shimizu, T.
    CANCER RESEARCH, 2012, 72
12345